Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Donohue James J. Insider Profile
4 Followers
Donohue James J., Director at Acurx Pharmaceuticals, holds 22.35K shares in Acurx Pharmaceuticals (Ticker: ACXP). Most recently, Donohue James J. Bought $9,852 shares of Acurx Pharmaceuticals on Jan 08, 2025 for an estimated value of 9.95K.
Donohue James J. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Donohue James J.'s holdings
Insider Roles
Director
Roles that Donohue James J. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Donohue James J.
Donohue James J.'s Trading History
List of latest transactions for each holding click on a transaction to see Donohue James J.'s performance on stock
You May Also Like
Donohue James J. insider profile FAQ
What is the percentage of profitable transactions made by Donohue James J.?
The percentage of profitable transactions made by Donohue James J. is ―.
What is the average return per transaction made by Donohue James J.?
The average return per transaction made by Donohue James J. is ―.
What stocks does Donohue James J. hold?
Donohue James J. holds: ACXP stocks.
What was Donohue James J.’s latest transaction?
Donohue James J. latest transaction was an Informative Buy of $9.95K.
What was Donohue James J.'s most profitable transaction?
Donohue James J.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Donohue James J.'s role in Acurx Pharmaceuticals?
Donohue James J.'s role in Acurx Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.